News
Latest News
"In spite of how important this issue is to consumers and businesses, this committee dragged its feet, and, instead, fixated on going after President Trump in an attempt to undo the 2016 election. That nonsense is now taking place in other committees rather than our own.
"Everyone knows that I believe in a strong patent system — that it’s essential to our economy, creating jobs and keeping America the world’s technology leader. Patents may be most important to the pharmaceutical and biologic industries.
"The Affordable Prescriptions for Patients Through Promoting Competition Act of 2019 strikes a good balance by giving the FTC the clear authority to prosecute cases in which a company has engaged in product hopping, without disincentivizing innovation to improve patient care.
"Growers are increasingly turning to the H-2A visa program to get the temporary labor they need, but the program needs reform. The agricultural industry wants and deserves a streamlined program that provides more certainty as to the temporary labor needed to sustain their businesses.
"With all the marijuana-related bills pending this Congress — including the bipartisan STATES Act — you have unfortunately chosen to markup the MORE Act today. This bill is nearly devoid of bipartisan support, and it fails to address many critical issues surrounding the cultivation, distribution, sale and use of marijuana."
" . . . the Federal Circuit continues to make decisions that illustrate what a mess the U.S. patent system has become. . . . The [Patent Eligibility Test] has upended confidence in patents in all industries from software and biotech innovations to mechanical inventions. Sadly, this begs the question: Are any patents safe from attack on eligibility grounds?
"Innovation and competition in the pharmaceutical market are key to lowering prescription drug costs. Anticompetitive tactics like product hopping are hurting American families, who are struggling to pay for expensive pharmaceuticals.
". . . this Democrat impeachment crusade lacks the due process protections afforded in all past presidential impeachments, including those protections afforded to President Clinton by Republicans.
"Now that Congress is officially engaged in a so-called 'impeachment inquiry,' it is incumbent upon you and the Democratic caucus to be faithful to your prior statement and to prioritize due process. In light of this, I hope that you join me in demanding the House take the same steps as have historically been taken to ensure fairness throughout impeachment proceedings."